Peripheral Vascular Devices | Market Insights | Europe | 2023
The COVID-19 pandemic had a negative impact on the European PV device market in 2020, and to some extent in 2021 and 2022. Following the impact of the pandemic, increasing physician awareness of the benefits of endovascular techniques over surgical interventions will drive growth in this market. Additionally, the launch of premium-priced devices, emerging clinical data, and improvements in reimbursement will support the European PV device market through the forecast period. However, revenue growth will be limited to some extent due to increasing price competition and ongoing cost constraints.
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for PV devices in Europe from 2019 through 2031.